Cas:25193-94-6 5-ethylpyrimidine manufacturer & supplier

We serve Chemical Name:5-ethylpyrimidine CAS:25193-94-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-ethylpyrimidine

Chemical Name:5-ethylpyrimidine
CAS.NO:25193-94-6
Synonyms:5-Aethyl-pyrimidin;5-ethyl-pyrimidine;Pyrimidine,5-ethyl;5-Ethylpyrimidin
Molecular Formula:C6H8N2
Molecular Weight:108.14100
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:108.06900
LogP:1.03900

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Aethyl-pyrimidin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Ethylpyrimidin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyrimidine,5-ethyl Use and application,Pyrimidine,5-ethyl technical grade,usp/ep/jp grade.


Related News: However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. 5-ethylpyrimidine manufacturer As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations. 5-ethylpyrimidine supplier Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 5-ethylpyrimidine vendor The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. 5-ethylpyrimidine factory The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.